Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3. This indicates a newer version of the study documentation associated with the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now indicates recruitment is closed with 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and records the latest Revision: v3.6.0 document.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page or its documentation rather than substantive changes to the study details.SummaryDifference0.0%

- Check46 days agoChange DetectedA new revision entry v3.5.4 has been added and the previous revision v3.5.3 has been removed, indicating an update to the documented revision history.SummaryDifference0.0%

- Check67 days agoChange DetectedThe study record shows updated metadata: the sponsor/links section and “last update” timing reflect a more recent posting (2026-04-24 and 2026-04-10/2026-04). Some study location entries have also changed by removing added ZIP+4 details, while the core study description and clinical components remain the same.SummaryDifference0.5%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.